162 related articles for article (PubMed ID: 8425213)
1. Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.
Hedlund G; Dohlsten M; Petersson C; Kalland T
Cancer Immunol Immunother; 1993; 36(2):89-93. PubMed ID: 8425213
[TBL] [Abstract][Full Text] [Related]
2. Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.
Belfrage H; Bhiladvala P; Hedlund G; Dohlsten M; Kalland T
Cancer Immunol Immunother; 1994 Apr; 38(4):265-71. PubMed ID: 8168122
[TBL] [Abstract][Full Text] [Related]
3. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
[TBL] [Abstract][Full Text] [Related]
4. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.
Lando PA; Hedlund G; Dohlsten M; Kalland T
Cancer Immunol Immunother; 1991; 33(4):231-7. PubMed ID: 2059967
[TBL] [Abstract][Full Text] [Related]
5. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.
Dohlsten M; Lando PA; Hedlund G; Trowsdale J; Kalland T
Immunology; 1990 Sep; 71(1):96-100. PubMed ID: 2210803
[TBL] [Abstract][Full Text] [Related]
6. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
7. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
9. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
10. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
[TBL] [Abstract][Full Text] [Related]
11. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases.
Li ZJ; Omoe K; Shinagawa K; Yagi J; Imanishi K
Microbiol Immunol; 2009 Aug; 53(8):451-9. PubMed ID: 19659929
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes.
Herrmann T; Romero P; Sartoris S; Paiola F; Accolla RS; Maryanski JL; MacDonald HR
J Immunol; 1991 Apr; 146(8):2504-12. PubMed ID: 1707909
[TBL] [Abstract][Full Text] [Related]
13. Superantigen-induced lysis of melanoma cells.
Krull F; Holzer U; Ihle J; Bethge W; Fierlbeck G; Kalland T; Dohlsten M; Niethammer D; Dannecker GE
Melanoma Res; 1997 Jun; 7(3):214-22. PubMed ID: 9195560
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
Dohlsten M; Abrahmsén L; Björk P; Lando PA; Hedlund G; Forsberg G; Brodin T; Gascoigne NR; Förberg C; Lind P
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8945-9. PubMed ID: 8090750
[TBL] [Abstract][Full Text] [Related]
15. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
[TBL] [Abstract][Full Text] [Related]
16. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
[TBL] [Abstract][Full Text] [Related]
17. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559
[TBL] [Abstract][Full Text] [Related]
18. Immune response during tumor therapy with antibody-superantigen fusion proteins.
Rosendahl A; Hansson J; Sundstedt A; Kalland T; Dohlsten M
Int J Cancer; 1996 Sep; 68(1):109-13. PubMed ID: 8895549
[TBL] [Abstract][Full Text] [Related]
19. Activation of T cells by superantigen in class II-negative mice.
Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
[TBL] [Abstract][Full Text] [Related]
20. Superantigen-induced anergy in cytotoxic CD8+ T cells.
Sundstedt A; Höidén I; Hansson J; Hedlund G; Kalland T; Dohlsten M
J Immunol; 1995 Jun; 154(12):6306-13. PubMed ID: 7759869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
